长春长生疫苗事件后广州家长儿童疫苗接种决策变化
研究于2019年3月1日至8日通过在线问卷对幼儿园家长开展横断面调查,共获14300份有效问卷,92.53%知晓疫苗事件。知晓者中13.62%选择可选疫苗或延迟、停止、拒绝接种,而非强制接种;疫苗事件知晓与儿童疫苗相关副作用自报在这两组更常见(P < 0.001),犹豫组更可能劝他人不接种(P < 0.001)。
要点
- 92.53%受访家长知晓长春长生疫苗事件。
- 知晓者中13.62%选择可选疫苗或延迟、停止、拒绝接种。
- 犹豫组更可能劝他人不接种(P < 0.001)。
核心结论
- 疫苗事件改变了家长对儿童接种的决策,需恢复公众信心并提升免疫接种率。
研究设计与样本
- 横断面研究,2019年3月1日至8日通过在线问卷联系幼儿园家长,获14300份有效问卷。
主要发现
- 92.53%的受访者知晓近期疫苗事件。
- 知晓者中13.62%倾向可选疫苗或延迟、停止、拒绝接种,而非强制接种。
- 疫苗事件知晓及儿童疫苗相关副作用自报在可选疫苗组和犹豫组更常见(P < 0.001)。
- 犹豫组较强制疫苗组更可能报告曾劝他人不接种(P < 0.001)。
临床怎么用
- 应采取措施恢复公众对疫苗的信心,并提升免疫接种率。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
A series of scandals involving the rabies vaccine and the diphtheria, tetanus, and pertussis combined vaccine (DTP) were reported in July 2018, in China. Our goal was to assess the effects of the vaccine scandal on parents' attitudes and decisions regarding vaccination. A cross-sectional study was conducted by contacting kindergarteners' parents through an online questionnaire from March 1 to 8, 2019. In total, 14,300 valid questionnaire responses were received, and 92.53% of respondents were aware of the recent vaccine scandal. Among parents who were aware of the vaccine scandal, 13.62% preferred that their children receive optional vaccines (optional vaccine group) or delay, stop or reject vaccinations (hesitate group) instead of receiving mandatory vaccines (mandatory vaccine group). Awareness of the vaccine scandal and self-reporting of vaccine-associated side effects in their children were more common among respondents in the optional vaccine and the hesitate groups (P < 0.001). Compared with the mandatory vaccine group, parents in the hesitate group were more likely to report having attempted to dissuade others from vaccinating their children (P < 0.001). Because the scandal changed parents' decisions regarding vaccination of their children, efforts should be made to restore public confidence in vaccines and to boost immunization rates.
引用
- He Q, Wang H, Ma Y, et al. Changes in parents' decisions pertaining to vaccination of their children after the Changchun Changsheng vaccine scandal in Guangzhou, China. Vaccine. 2020. PMID: 32891473. doi:10.1016/j.vaccine.2020.08.039
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。